OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

RNA-Binding Protein HuR Promotes Th17 Cell Differentiation and Can Be Targeted to Reduce Autoimmune Neuroinflammation
Jing Chen, Jennifer L. Martindale, Kotb Abdelmohsen, et al.
The Journal of Immunology (2020) Vol. 204, Iss. 8, pp. 2076-2087
Open Access | Times Cited: 28

Showing 1-25 of 28 citing articles:

RNA packaging into extracellular vesicles: An orchestra of RNA‐binding proteins?
Fabrizio Fabbiano, Jessica Corsi, Elena Gurrieri, et al.
Journal of Extracellular Vesicles (2020) Vol. 10, Iss. 2
Open Access | Times Cited: 202

RBP–RNA interactions in the control of autoimmunity and autoinflammation
Juan Liu, Xuetao Cao
Cell Research (2023) Vol. 33, Iss. 2, pp. 97-115
Open Access | Times Cited: 43

Control of RNA Stability in Immunity
Shizuo Akira, Kazuhiko Maeda
Annual Review of Immunology (2021) Vol. 39, Iss. 1, pp. 481-509
Closed Access | Times Cited: 65

HuR as a molecular target for cancer therapeutics and immune-related disorders
Mrinmoyee Majumder, Paramita Chakraborty, Sarumathi Mohan, et al.
Advanced Drug Delivery Reviews (2022) Vol. 188, pp. 114442-114442
Open Access | Times Cited: 57

Targeting the “tumor microenvironment”: RNA-binding proteins in the spotlight in colorectal cancer therapy
Yiwei Zhang, Yujun Zhang, Jingjing Song, et al.
International Immunopharmacology (2024) Vol. 131, pp. 111876-111876
Closed Access | Times Cited: 9

CRC-derived exosomes containing the RNA binding protein HuR promote lung cell proliferation by stabilizing c-Myc mRNA
Hui Xiao, Xiong Ye, Vikalp Vishwakarma, et al.
Cancer Biology & Therapy (2022) Vol. 23, Iss. 1, pp. 139-149
Open Access | Times Cited: 32

Roles of RNA-binding proteins in immune diseases and cancer
Shigeru Hashimoto, Tadamitsu Kishimoto
Seminars in Cancer Biology (2022) Vol. 86, pp. 310-324
Closed Access | Times Cited: 28

RNA-binding proteins in vascular inflammation and atherosclerosis
Marco Sachse, Simon Tual‐Chalot, Giorgia Ciliberti, et al.
Atherosclerosis (2023) Vol. 374, pp. 55-73
Open Access | Times Cited: 13

Effects of genetic ablation and pharmacological inhibition of HuR on gene expression, iron metabolism, and hormone levels
Nathalie Idlin, Sivakumar Krishnamoorthy, Magdalena Wołczyk, et al.
BMC Biology (2025) Vol. 23, Iss. 1
Open Access

Regulatory Effects of RNA–Protein Interactions Revealed by Reporter Assays of Bacteria Grown on Solid Media
Guillermo Pérez-Ropero, Roswitha Dolcemascolo, Anna Pérez‐Ràfols, et al.
Biosensors (2025) Vol. 15, Iss. 3, pp. 175-175
Open Access

HuR-targeted agents: An insight into medicinal chemistry, biophysical, computational studies and pharmacological effects on cancer models
Giulia Assoni, Valeria La Pietra, Rosangela Digilio, et al.
Advanced Drug Delivery Reviews (2021) Vol. 181, pp. 114088-114088
Closed Access | Times Cited: 21

CRISPR/Cas9-Mediated Knockout of the HuR Gene in U251 Cell Inhibits Japanese Encephalitis Virus Replication
Sai-Qi Luo, Sanjie Cao, Qin Zhao
Microorganisms (2024) Vol. 12, Iss. 2, pp. 314-314
Open Access | Times Cited: 3

RUNX1/EGFR pathway contributes to STAT3 activation and tumor growth caused by hyperactivated mTORC1
Wei Lin, Xiaofeng Wan, Anjiang Sun, et al.
Molecular Therapy — Oncolytics (2021) Vol. 23, pp. 387-401
Open Access | Times Cited: 15

Long Noncoding RNA HAFML Promotes Migration and Invasion of Rheumatoid Fibroblast-like Synoviocytes
Siqi Xu, Di Liu, Yu Kuang, et al.
The Journal of Immunology (2023) Vol. 210, Iss. 2, pp. 135-147
Open Access | Times Cited: 6

Interactome Networks of FOSL1 and FOSL2 in Human Th17 Cells
Ankitha Shetty, Santosh D. Bhosale, Subhash Tripathi, et al.
ACS Omega (2021) Vol. 6, Iss. 38, pp. 24834-24847
Open Access | Times Cited: 12

The RNA regulatory programs that govern lymphocyte development and function
Manuel D. Díaz‐Muñoz, Inés C. Osma-García
Wiley Interdisciplinary Reviews - RNA (2021) Vol. 13, Iss. 1
Closed Access | Times Cited: 11

Targeting the RNA-Binding Protein HuR as Potential Thera-Peutic Approach for Neurological Disorders: Focus on Amyo-Trophic Lateral Sclerosis (ALS), Spinal Muscle Atrophy (SMA) and Multiple Sclerosis
Vittoria Borgonetti, Elisabetta Coppi, Nicoletta Galeotti
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 19, pp. 10394-10394
Open Access | Times Cited: 11

Leveraging Exosomes as the Next-Generation Bio-Shuttles: The Next Biggest Approach against Th17 Cell Catastrophe
Snigdha Samarpita, Xiaogang Li
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 8, pp. 7647-7647
Open Access | Times Cited: 4

HuR Plays a Positive Role to Strengthen the Signaling Pathways of CD4+ T Cell Activation and Th17 Cell Differentiation
Shiguang Yu, Morgan Tripod, Ulus Atasoy, et al.
Journal of Immunology Research (2021) Vol. 2021, pp. 1-13
Open Access | Times Cited: 10

RNA-Binding Proteins as Epigenetic Regulators of Brain Functions and Their Involvement in Neurodegeneration
Carlo Maria Di Liegro, Gabriella Schiera, Giuseppe Schirò, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 23, pp. 14622-14622
Open Access | Times Cited: 7

RNA-binding protein HuR reprograms immune T cells and promotes oral squamous cell carcinoma
Mrinmoyee Majumder, Harinarayanan Janakiraman, Paramita Chakraborty, et al.
Oral Oncology Reports (2024) Vol. 10, pp. 100296-100296
Open Access | Times Cited: 1

ELAVL1‐dependent SOAT2 exacerbated the pancreatitis‐like cellular injury of AR42J cells induced by hyperstimulation with caerulein
Yusha Sun, Huaying Chen, Xiaomin Lai
The Kaohsiung Journal of Medical Sciences (2024)
Open Access | Times Cited: 1

Autotaxin in encephalitogenic CD4 T cells as a therapeutic target for multiple sclerosis
Cora L. Petersen‐Cherubini, Shawn P. Murphy, Matthew Xin, et al.
European Journal of Immunology (2023) Vol. 54, Iss. 1
Open Access | Times Cited: 2

HuR-Targeted Inhibition Impairs Th2 Proinflammatory Responses in Asthmatic CD4+ T Cells
Fatemeh Fattahi, Jason S. Ellis, Michael Sylvester, et al.
The Journal of Immunology (2021) Vol. 208, Iss. 1, pp. 38-48
Open Access | Times Cited: 4

Page 1 - Next Page

Scroll to top